In a study on hepatocellular carcinoma, NAT10 expression was significantly upregulated in cancerous tissues, and its expression level was negatively correlated with the OS of patients, suggesting that it is an oncogene (Li et al., 2017). Here, NAT10 is linked to hepatocellular carcinoma.